Yoshihisa Matsukawa Selected Research

silodosin

4/2021	Effects of tadalafil versus silodosin on voiding function in male patients with non-neurogenic detrusor underactivity: A comparative study using propensity score matching.
1/2020	Factors contributing to the efficacy of two add-on therapies of fesoterodine or mirabegron to silodosin monotherapy for persistent overactive bladder in men with lower urinary tract symptoms.
1/2019	Comparison in the efficacy of fesoterodine or mirabegron add-on therapy to silodosin for patients with benign prostatic hyperplasia complicated by overactive bladder: A randomized, prospective trial using urodynamic studies.
9/2018	Two-year follow up of silodosin on lower urinary tract functions and symptoms in patients with benign prostatic hyperplasia based on prostate size: a prospective investigation using urodynamics.
10/2017	Effects of Withdrawing α1-Blocker from Combination Therapy with α1-Blocker and 5α-Reductase Inhibitor in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Prospective and Comparative Trial Using Urodynamics.
1/2017	Intravesical prostatic protrusion can predict therapeutic response to silodosin in male patients with lower urinary tract symptoms.
1/2017	Intraprostatic Reflux of Urine Induces Inflammation in a Rat.
1/2017	Comparison of Silodosin and Naftopidil for Efficacy in the Treatment of Benign Prostatic Enlargement Complicated by Overactive Bladder: A Randomized, Prospective Study (SNIPER Study).
2/2016	The Change of Testosterone Secretion During the Treatment of Alpha-1 Blocker in Patients with Benign Prostatic Hyperplasia.
3/2013	What are the factors contributing to failure in improvement of subjective symptoms following silodosin administration in patients with benign prostatic hyperplasia? Investigation using a pressure-flow study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshihisa Matsukawa Research Topics

Disease

19	Lower Urinary Tract Symptoms 01/2022 - 12/2009
12	Neoplasms (Cancer) 07/2022 - 08/2005
12	Overactive Urinary Bladder (Overactive Bladder) 01/2022 - 03/2008
11	Prostatic Neoplasms (Prostate Cancer) 02/2022 - 04/2009
11	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 12/2020 - 01/2013
11	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 05/2019 - 09/2011
6	Urinary Incontinence 04/2021 - 01/2010
5	Noninfiltrating Intraductal Carcinoma (DCIS) 12/2020 - 02/2016
5	Renal Cell Carcinoma (Grawitz Tumor) 05/2019 - 08/2005
5	Stress Urinary Incontinence 01/2019 - 01/2010
4	Pain (Aches) 01/2022 - 02/2016
4	Underactive Urinary Bladder 04/2021 - 04/2008
4	Peritoneal Fibrosis 01/2018 - 03/2010
3	Neoplasm Metastasis (Metastasis) 02/2021 - 07/2008
3	Fibrosis (Cirrhosis) 01/2018 - 03/2010
2	Carcinoma (Carcinomatosis) 07/2022 - 04/2009
2	Pelvic Pain 01/2022 - 01/2020
2	Prostatitis 01/2022 - 01/2020
2	Seminoma 01/2018 - 07/2008
2	Peritonitis 01/2016 - 10/2013
2	Hyperplasia 09/2011 - 04/2011
2	Ischemia 11/2010 - 05/2005
2	Hemorrhage 04/2009 - 08/2005
1	Hyperlipidemias (Hyperlipidemia) 01/2022
1	Adenocarcinoma 02/2021
1	Hypertrophy 08/2020
1	Disease Progression 11/2019
1	Solitary Kidney 05/2019
1	Sarcopenia 01/2019
1	Cerebral Hemorrhage 01/2019
1	Margins of Excision 01/2019
1	Rhabdomyosarcoma 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Inguinal Hernia (Direct Inguinal Hernia) 06/2018
1	Colitis 01/2018
1	Paraganglioma (Paragangliomas) 01/2018
1	Teratoma (Teratoid Tumor) 01/2018
1	Inflammation (Inflammations) 01/2017
1	Hypoxia (Hypoxemia) 01/2017

Drug/Important Bio-Agent (IBA)

12	silodosin FDA Link 04/2021 - 12/2009
5	Tadalafil (Cialis)FDA Link 04/2021 - 01/2018
5	Prostate-Specific Antigen (Semenogelase)IBA 01/2020 - 02/2016
5	naftopidilIBA 01/2019 - 04/2011
4	mirabegronIBA 08/2020 - 04/2015
3	Testosterone (Sustanon)FDA Link 01/2022 - 02/2016
3	Therapeutic UsesIBA 12/2020 - 09/2017
3	Dutasteride (Avodart)FDA Link 10/2017 - 08/2014
3	Tamsulosin (Flomax)FDA LinkGeneric 01/2013 - 11/2010
2	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2017
2	Docetaxel (Taxotere)FDA Link 02/2021 - 06/2018
2	fesoterodine FDA Link 01/2020 - 01/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 01/2018
2	Vincristine (Oncovin)FDA LinkGeneric 01/2019 - 01/2018
2	Dialysis SolutionsIBA 01/2018 - 03/2010
2	Messenger RNA (mRNA)IBA 01/2018 - 03/2010
2	cytidylyl-(3'-5')-cytidine (CpC)IBA 02/2009 - 05/2005
1	pembrolizumabIBA 07/2022
1	GP 4 (GP4)IBA 04/2021
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2021
1	Hormones (Hormone)IBA 12/2020
1	Androgen Receptors (Androgen Receptor)IBA 11/2020
1	salicylhydroxamic acid (SHAM)IBA 08/2020
1	indolepropanol phosphate (IPP)IBA 01/2020
1	AndrogensIBA 01/2020
1	Androgen Antagonists (Antiandrogens)IBA 11/2019
1	Flutamide (Eulexin)FDA LinkGeneric 11/2019
1	bicalutamide (Casodex)FDA LinkGeneric 11/2019
1	Sunitinib (Sutent)FDA Link 05/2019
1	AlbuminsIBA 01/2019
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2019
1	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2019
1	C-Reactive ProteinIBA 01/2019
1	Serum AlbuminIBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	resiniferatoxinIBA 01/2018
1	CatecholaminesIBA 01/2018
1	Dacarbazine (DIC)FDA LinkGeneric 01/2018
1	Minocycline (Cyclops)FDA LinkGeneric 01/2018
1	Sulfonic AcidsIBA 01/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Pharmaceutical PreparationsIBA 09/2017
1	8-Hydroxy-2'-DeoxyguanosineIBA 05/2017
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2017
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2017

Therapy/Procedure

14	Therapeutics 02/2022 - 03/2010
14	Prostatectomy (Retropubic Prostatectomy) 04/2021 - 04/2008
5	Nephrectomy 01/2018 - 08/2005
4	Castration 12/2020 - 06/2018
4	Peritoneal Dialysis 01/2018 - 03/2010
3	Drug Therapy (Chemotherapy) 01/2019 - 01/2018
3	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2014 - 01/2010
2	Aftercare (After-Treatment) 01/2019 - 01/2018
2	Radiotherapy 01/2018 - 01/2018
1	Metastasectomy 02/2022
1	Massage (Zone Therapy) 01/2022
1	Urinary Catheters 04/2021
1	Pelvic Exenteration 02/2021
1	Solid-State Lasers 01/2019